Request a Free IMF Info Pack
The IMF InfoPack includes the following publications, free of charge.
Publications helpful to all myeloma patients and care partners
- IMF Patient Handbook for Multiple Myeloma: Overview of the Disease and Treatment Options
- Understanding Clinical Trials
- Understanding DARZALEX® (daratumumab) and DARZALEX FASPRO® (daratumumab + hyaluronidase-fihj)
- Understanding Dexamethasone in the Treatment of Myeloma
- Understanding Myeloma Vocabulary
- Understanding REVLIMID® (lenalidomide)
- Understanding SARCLISA® (isatuximab-irfc)
- Understanding Treatment of Myeloma Bone Disease
- Understanding VELCADE® (bortezomib)
- Understanding the VRd Regimen for Newly Diagnosed Myeloma
- Understanding Your Test Results
- Tip Card: What Is Multiple Myeloma? | What Is the IMF?
- Tip Card: Myeloma Treatment Discussion Tool
- Tip Card: Care Partners Can Help Patients Live Well with Myeloma
- Myeloma Today – a sample edition of the IMF quarterly journal
These publications address the treatment of myeloma later in the disease course.
- Understanding ABECMA® (idecabtagene vicleucel)
- Understanding CARVYKTI® (ciltacabtagene autoleucel)
- Understanding ELREXFIO™ (elranatamab-bcmm)
- Understanding EMPLICITI® (elotuzumab)
- Understanding KYPROLIS® (carfilzomib)
- Understanding NINLARO® (ixazomib)
- Understanding POMALYST® (pomalidomide)
- Understanding TALVEY® (talquetamab-tgvs)
- Understanding TECVAYLI® (teclistamab-cqyv)
- Understanding XPOVIO® (selinexor)